ACADIA Pharmaceuticals, Inc. (ACAD)
24.33
+1.13
(+4.87%)
USD |
NASDAQ |
Feb 19, 16:00
24.33
0.00 (0.00%)
Pre-Market: 08:02
ACADIA Pharmaceuticals Research and Development Expense (Quarterly) : 87.83M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.346M |
| Dynavax Technologies Corp. | 19.12M |
| Axsome Therapeutics, Inc. | 40.04M |
| Rhythm Pharmaceuticals, Inc. | 45.92M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |